RAY THERAPEUTICS
Ray Therapeutics is a biotech company developing optogenetic gene therapies for patients with blinding diseases.
RAY THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2021-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.raytherapeutics.com
Total Employee:
11+
Status:
Active
Total Funding:
10 M USD
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Aukera Therapeutics
Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein related diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
California Institute of Regenerative Medicine (CIRM)
California Institute of Regenerative Medicine (CIRM) investment in Grant - Ray Therapeutics
4BIO Capital
4BIO Capital investment in Seed Round - Ray Therapeutics
Official Site Inspections
http://www.raytherapeutics.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ray Therapeutics"
Ray Therapeutics
Restoring vision with the power of optogeneticsSee details»
About Us - Ray Therapeutics
Paul Bresge has been a leader in the cell and gene therapy biotech space for over a decade. He is co-founder and Chief Executive Officer at Ray Therapeutics, an optogenetics gene therapy …See details»
Ray Therapeutics, Inc. | LinkedIn
Ray Therapeutics Inc (RayTx) is a late-stage preclinical Bay Area biotechnology company pioneering the first-to-market precision optogenetic therapy for vision restoration that is highly active...See details»
Clinical Trials - Ray Therapeutics
RayTx established The Vision Research and Assessment Institute (VRAI) with the express purpose of serving as a testing facility for efficacy endpoints for patients with Low Vision.See details»
Ray Therapeutics - Crunchbase Company Profile & Funding
Ray Therapeutics is a company that creates novel optogenetic gene therapies for patients with blinding diseases. The company develops technology to study and learn about rare retinal …See details»
Ray Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Ray Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Ray Therapeutics Licenses Delivery Technology for …
Ray Therapeutics is developing novel optogenetics gene therapies for patients with blinding diseases. The company is developing its lead candidate RTx-015 in retinitis pigmentosa, a degenerative retinal disease with significant unmet …See details»
Ray Therapeutics Closes Oversubscribed $100M Series …
May 16, 2023 · Ray Therapeutics has developed an optogenetic platform to bioengineer a next generation pipeline of genotype independent therapeutics for vision restoration in multiple retinal diseases where the...See details»
4BIO Capital Portfolio Company Ray Therapeutics Closes …
May 16, 2023 · London & San Francisco, CA, 16 May 2023 – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm unlocking the treatments of the future by …See details»
Ray Therapeutics Company Profile - Office Locations ... - Craft
Ray Therapeutics is a biotech company developing gene therapies for patients with blinding diseases. It focuses on optogenetics to restore vision in patients with retinitis pigmentosa. The …See details»
News - Ray Therapeutics
Funds will advance Ray Therapeutics’ optogenetics gene therapy programs for blinding retinal diseases…. We’re delighted to present our data which shows the power of visual optogenetics as a disruptive technology with the potential to …See details»
Ray Therapeutics - Contacts, Employees, Board Members
Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.See details»
Biotech startup Ray raises $100M for vision-restoring gene therapies
May 16, 2023 · Ray Therapeutics, a privately held, 2-year-old biotechnology startup, has raised $100 million to fund development of gene therapies that can restore visual function in people …See details»
Ray Therapeutics and Forge Biologics Announce Viral Vector …
Mar 1, 2022 · Ray Therapeutics is developing novel optogenetics gene therapies for patients with blinding diseases. The company is developing its lead candidate Ray-001 in retinitis …See details»
Ray Therapeutics Closes $6M Seed Financing to Advance Novel ...
Jan 4, 2022 · Ray Therapeutics is developing novel optogenetics gene therapies for patients with blinding diseases. The company is developing its lead candidate Ray-001 in retinitis …See details»
Science - Ray Therapeutics
Ray’s Vision for Patients: RESTORE vision to those who are blind or visually impaired. Our technology looks to realize the full potential of a pioneering scientific field called Optogenetics. …See details»
Ray Therapeutics Raises $100M Series A to Fuel Gene Therapy for ...
May 17, 2023 · Ray Therapeutics, an optogenetics start-up founded in 2021, has announced a $100M Series A financing round led by Novo Holdings A/S. The funding will advance multiple …See details»
Ray Therapeutics Tackles a Rare Blinding Disease With $100 …
May 16, 2023 · Venture investors have provided $100 million in fresh funding to Ray Therapeutics, a biotech company seeking to restore vision in people with the rare blinding …See details»
Careers - Ray Therapeutics
We’re passionate about developing transformative therapies to improve the lives of patients by developing best-in-class treatments for blinding diseases using optogenetics. Our success …See details»
Pipeline - Ray Therapeutics
Pipeline Addressing a range of degenerative retinal diseases Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on …See details»